<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(3)</volume><submitter>Muttamba W</submitter><funding>World Bank-EAPHLNP</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Xpert MTB/RIF assay is a highly sensitive test for TB diagnosis, but still costly to most low-income countries. Several implementation strategies instead of frontline have been suggested; however with scarce data. We assessed accuracy of different Xpert MTB/RIF implementation strategies to inform national roll-out.&lt;h4>Methods&lt;/h4>This was a cross-sectional study of 1,924 adult presumptive TB patients in five regional referral hospitals of Uganda. Two sputum samples were collected, one for fluorescent microscopy (FM) and Xpert MTB/RIF examined at the study site laboratories. The second sample was sent to the Uganda Supra National TB reference laboratory for culture using both Lowenstein Jensen (LJ) and liquid culture (MGIT). We compared the sensitivities of FM, Xpert MTB/</pubmed_abstract><journal>PloS one</journal><pagination>e0194741</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5864038</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.</pubmed_title><pmcid>PMC5864038</pmcid><pubmed_authors>Joloba M</pubmed_authors><pubmed_authors>Muttamba W</pubmed_authors><pubmed_authors>Sekibira R</pubmed_authors><pubmed_authors>Ssengooba W</pubmed_authors><pubmed_authors>Kirenga B</pubmed_authors><pubmed_authors>Katamba A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.</name><description>&lt;h4>Background&lt;/h4>Xpert MTB/RIF assay is a highly sensitive test for TB diagnosis, but still costly to most low-income countries. Several implementation strategies instead of frontline have been suggested; however with scarce data. We assessed accuracy of different Xpert MTB/RIF implementation strategies to inform national roll-out.&lt;h4>Methods&lt;/h4>This was a cross-sectional study of 1,924 adult presumptive TB patients in five regional referral hospitals of Uganda. Two sputum samples were collected, one for fluorescent microscopy (FM) and Xpert MTB/RIF examined at the study site laboratories. The second sample was sent to the Uganda Supra National TB reference laboratory for culture using both Lowenstein Jensen (LJ) and liquid culture (MGIT). We compared the sensitivities of FM, Xpert MTB/</description><dates><release>2018-01-01T00:00:00Z</release><publication>2018</publication><modification>2025-04-19T02:28:19.342Z</modification><creation>2019-03-26T23:20:40Z</creation></dates><accession>S-EPMC5864038</accession><cross_references><pubmed>29566056</pubmed><doi>10.1371/journal.pone.0194741</doi></cross_references></HashMap>